![Scott Gleason](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Gleason
Finanzdirektor/CFO bei
SERA PROGNOSTICS, INC.
Vermögen: 240 565 $ am 31.07.2026
Profil
Mr. Scott K.
Gleason is a Chief Financial Officer & Treasurer at Sera Prognostics, Inc. and a Head-Investor Relations at Neogen Corp.
Mr. Gleason was previously employed as a Senior VP-Investor Relations & Communications by OraSure Technologies, Inc., a Senior Vice President-Investor Relations by Myriad Genetics, Inc., and a Research Analyst by Stephens, Inc. He received his undergraduate degree from United States Air Force Academy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.08.2026 | 117.924 ( 0,31 % ) | 240 565 $ | 31.07.2026 |
Aktive Positionen von Scott Gleason
| Unternehmen | Position | Beginn |
|---|---|---|
| NEOGEN CORPORATION | Investor Relations Kontakt | - |
| SERA PROGNOSTICS, INC. | Finanzdirektor/CFO | 31.08.2026 |
Ehemalige bekannte Positionen von Scott Gleason
| Unternehmen | Position | Ende |
|---|---|---|
| ORASURE TECHNOLOGIES, INC. | Finanzdirektor/CFO | 08.08.2022 |
Stephens, Inc.
 Stephens, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.01.2013 |
| MYRIAD GENETICS, INC. | Investor Relations Kontakt | - |
Ausbildung von Scott Gleason
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Neogen Corp.
 Neogen Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical testing kits | Health Technology |
Stephens, Inc.
Stephens, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
OraSure Technologies, Inc.
 OraSure Technologies, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, markets and sells oral fluid specimen collection devices | Health Technology |
United States Air Force Academy
 United States Air Force Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sera Prognostics, Inc.
 Sera Prognostics, Inc. Medical/Nursing ServicesHealth Services Provides personalized diagnostics to predict and manage pregnancy complications | Health Services |
